as on January 9, 2026 at 4:01 pm IST
Day's Low
Day's High
7.83%
Downside
1.74%
Upside
52 Week's Low
52 Week's High
33.77%
Downside
39.79%
Upside
as on January 9, 2026 at 4:01 pm IST
Market Cap
₹21.17 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.49
P/B Ratio
-22.63
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-106.67
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Venmax Drugs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 21.17 | 60.36% | 0.00 | -1 | NA | |
| BUY | 22,401.82 | -2.26% | 0.69 | 91 | 9,151 | |
| NA | 349.84 | 40.76% | 0.69 | 7 | 155 | |
| NA | 5.93 | -12.51% | 0.00 | -6 | NA | |
| NA | 38.77 | 1.63% | 0.50 | 1 | 67 |
Get share price movements and forecasts by analysts on Venmax Drugs.
Source: S&P Global Market Intelligence
Search interest for Venmax Drugs & Pharmaceuticals Ltd Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venmax Drugs.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 106.67% since last year same period to ₹0.02Cr in the Q2 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -50% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Venmax Drugs stock has moved up by 2.8%
Best in 1 Year
![]()
In the last 1 year, Venmax Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 23.14% of holdings in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 76.87% to 76.87% in Sep 2025 quarter
| Organisation | Venmax Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Venmax Drugs share price today stands at ₹26.44 as on at the close of the market. Venmax Drugs share today touched a day high of ₹26.9 and a low of ₹24.37.
Venmax Drugs touched a 52 week high of ₹36.96 and a 52 week low of ₹17.51. Venmax Drugs share price today i.e. is closed at ₹26.44, which is -28.46% down from its 52 week high and 51.00% up from its 52 week low.
Venmax Drugs market capitalisation is ₹21.17 Cr as on .
To buy Venmax Drugs shares, you need to follow these steps:
Venmax Drugs trading volume is 699.00 as on . This means that 699.00 shares of Venmax Drugs were bought and sold on the stock market during today's trading session.